Among persons with HIV, more finish short-course TB prophylaxis

(HealthDay)—Tuberculosis preventive treatment completion is higher with three months of rifapentine-isoniazid than six months of isoniazid among patients with HIV receiving antiretroviral therapy, according to a study published ...


Advancing the long-term well-being of people living with HIV

Since antiretroviral therapy (ART) for HIV was introduced in 1996, AIDS-related morbidity and mortality has declined significantly. People living with HIV are now expected to live nearly as long as people without HIV. Despite ...


UN optimistic on conquering AIDS by 2030

Forty years on since the first AIDS cases were reported, the United Nations said Thursday it was cautiously optimistic that the human immunodeficiency virus (HIV)—the virus that causes the disease—could be beaten by 2030.


The state of HIV screening, diagnosis and treatment in the U.S.

In a new feature in the New England Journal of Medicine, Michael Saag, M.D., professor with the University of Alabama at Birmingham Division of Infectious Diseases and director of the UAB Center for AIDS Research, details ...


A brand new cocktail to fight HIV

Researchers at the University of Montreal Hospital Research Centre (CRCHUM) and Yale University have succeeded in reducing the size of the HIV reservoir in humanized mice by using a "molecular can opener" and a combination ...


Noncalcified coronary plaque burden higher in people with HIV

People living with human immunodeficiency virus (HIV) and without known cardiovascular disease have two to three times the noncalcified coronary plaque burden of non-HIV healthy volunteers, according to a study from Canada ...

page 1 from 40